Dexiderm Scalp

Natural health product licensed in Canada

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source
3-Pyridinecarboxamide	4 % (p/p)

Caprylate de glycéryle, Laurate/succinate de poly(glycéryle-4), Gomme de xanthane, Alcool benzylique, Eau purifiée, Glycérol

Population	Age	Quantity per serving	Frequency
Adultes	Not specified	1 Portion(s)	2 Tous les jours

Helps in the management and relief of the signs and symptoms of moderate to severe dandruff (erythema, scaling and pruritus).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Contre-indications
Contraindicated in any patient with a known history of allergy to any of the ingredients.
Effets indésirables connus
May be associated with mild tingling or itching, primarily during the first days of application.
Précautions et mises en garde
For external use only. Avoid eye contact. If contact occurs, rinse thoroughly with water. Consult your health care practitioner prior to use if pregnant or breastfeeding. Not suitable for children under 18 years or younger.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.